I take death in trials as a lower bound. They pick the participants and the size of the trial.
A single death suggests that the drug may be fatal to some, but there is not sufficient statistical power for the trial to estimate for how many. Just like they like it.
I take death in trials as a lower bound. They pick the participants and the size of the trial.
A single death suggests that the drug may be fatal to some, but there is not sufficient statistical power for the trial to estimate for how many. Just like they like it.
That is a good point. But with the vax, it's probably the vax.
That is a good point. But with the vax, it's probably the vax.
(post is archived)